login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
INVIVYD INC (IVVD) Stock News
USA
-
Nasdaq
- NASDAQ:IVVD -
US00534A1025
-
Common Stock
2.29
USD
+0.01 (+0.44%)
Last: 12/18/2025, 8:00:02 PM
2.31
USD
+0.02 (+0.87%)
Pre-Market:
12/19/2025, 8:01:27 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IVVD Latest News, Press Relases and Analysis
All
Press Releases
24 days ago - By: Invivyd
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
24 days ago - By: Invivyd
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
25 days ago - By: Invivyd
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
25 days ago - By: Invivyd
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
a month ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
a month ago - By: Benzinga
Examining the Future: Invivyd's Earnings Outlook
a month ago - By: Stocktwits
Invivyd Stock Hits 19-Month High As Public Offering Lands Days After Point72, Janus Henderson Reveal Big Stakes
a month ago - By: Invivyd
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
a month ago - By: Invivyd
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
a month ago - By: Invivyd
Invivyd Announces Proposed Public Offering of Common Stock
a month ago - By: Invivyd
Invivyd Announces Proposed Public Offering of Common Stock
a month ago - By: Invivyd
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
a month ago - By: Invivyd
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
a month ago - By: Zacks Investment Research
- Mentions:
RXRX
Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates
a month ago - By: Zacks Investment Research
- Mentions:
VRDN
Viridian Therapeutics, Inc. (VRDN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
2 months ago - By: Invivyd
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
2 months ago - By: Invivyd
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
2 months ago - By: Invivyd
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
2 months ago - By: Invivyd
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Please enable JavaScript to continue using this application.